You're viewing a public preview of Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease

Inactive
United States
Sector: Life Science Entity: Private
Merged Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease merged into Humanigen, Inc. in 2015
2
Transactions
Sign up to view
$3M
Deal Value
Sign up to view
About Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease
Operating in the Life Science industry, Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is based in United States. Investors on record include Humanigen, Inc.. The company is headquartered in United States. Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease appears in AcquityData's private market intelligence platform.
Investors
Current Investors
Humanigen, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease do?
Operating in the Life Science industry, Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is based in United States. Investors on record include Humanigen, Inc.. The company is headquartered in United States. Savant Neglected Diseases - Benznidazole Program for the
Where is Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease headquartered?
Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is headquartered in United States.
When was Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease founded?
Founded year information for Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease is available on AcquityData.
What sector is Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease in?
Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease operates in the Life Science sector.
Who are the investors in Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease?
Current investors in Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease include Humanigen, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease been involved in?
Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Savant Neglected Diseases - Benznidazole Program for the Treatment of Chagas Disease's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial